Richard Knox

Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.

Among other things, Knox's NPR reports have examined the impact of HIV/AIDS in Africa, North America, and the Caribbean; anthrax terrorism; smallpox and other bioterrorism preparedness issues; the rising cost of medical care; early detection of lung cancer; community caregiving; music and the brain; and the SARS epidemic.

Before joining NPR, Knox covered medicine and health for The Boston Globe. His award-winning 1995 articles on medical errors are considered landmarks in the national movement to prevent medical mistakes. Knox is a graduate of the University of Illinois and Columbia University. He has held yearlong fellowships at Stanford and Harvard Universities, and is the author of a 1993 book on Germany's health care system.

He and his wife Jean, an editor, live in Boston. They have two daughters.

Pages

Shots - Health News
4:05 pm
Wed August 28, 2013

Illicit Drugs And Mental Illness Take A Huge Global Toll

A homeless man smokes crack in the Barrio Triste neighborhood in Medellin, Colombia.
Raul Arboleda AFP/Getty Images

Mental disorders and substance abuse are the leading causes of nonfatal illness on the planet, according to an ambitious analysis of data from around the world.

A companion report, the first of its kind, documents the global impact of four illicit drugs: heroin and other opiates, amphetamines, cocaine and cannabis. It calls illegal drugs "an important contributor to the global burden of disease."

The two papers are being published by The Lancet as part of a continuing project called the Global Burden of Disease.

Read more
Shots - Health News
5:03 pm
Tue August 27, 2013

Vaccinating Babies For Rotavirus Protects The Whole Family

An artistic illustration of the rotavirus.
petersimoncik iStockPhoto.com

Originally published on Wed August 28, 2013 3:40 pm

A 7-year-old vaccine that has drastically cut intestinal infections in infants is benefiting the rest of America, too.

A study published Tuesday from the Centers for Disease Control and Prevention shows that vaccinating infants against rotavirus has also caused a striking decline in serious infections among older children and adults who didn't get vaccinated.

Read more
Shots - Health News
11:46 am
Tue August 27, 2013

More Stroke Patients Now Get Clot-Busting Drug

A brain scan followed by quick drug treatment in the right patients can stop a stroke in its tracks.
iStockphoto.com

Originally published on Wed August 28, 2013 11:14 am

It's been a long and often controversial road, but U.S. doctors are finally embracing a drug that can halt strokes and prevent disabling brain damage.

An analysis of more than 1 million stroke patients shows that use of the 17-year-old drug, called alteplase (brand-name Activase), nearly doubled between 2003 and 2011.

Read more
Shots - Health News
10:18 am
Fri August 23, 2013

Another Study Of Preemies Blasted Over Ethical Concerns

What should parents be told before their premature infants participate in a clinical study?
iStockphoto.com

Originally published on Fri August 23, 2013 11:09 am

For the second time in four months, the consumer group Public Citizen is alleging that a large, federally funded study of premature infants is ethically flawed.

Both complaints raise a big issue that's certain to get more attention beyond these particular studies: What's the ethically right way to do research on the validity of the usual care that doctors provide every day.

The U.S. Department of Health and Human Services will host an unusual forum on that question next Wednesday — stimulated by the sharp questions raised by Public Citizen.

Read more
Shots - Health News
1:03 pm
Wed August 21, 2013

Ebola Treatment Works In Monkeys, Even After Symptoms Appear

The Ebola virus forms threadlike structures under the microscope.
Cynthia Goldsmith CDC

Originally published on Wed August 21, 2013 7:58 pm

Ebola, your days as one of the world's scariest diseases may be numbered.

A team of U.S. government researchers has shown that deadly Ebola hemorrhagic fever can be vanquished in monkeys by an experimental drug given up to five days after infection — even when symptoms have already developed.

An antibody cocktail aimed at Ebola's outer surface rescued three of seven macaques infected with lethal doses of the hemorrhagic virus in the U.S. Army's high-security labs at Fort Detrick, Md.

Read more

Pages